Agenus reported $-64672000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Amgen AMGN:US $ 3228M 40M
AstraZeneca AZN:LN 2784M 588M
Bristol Myers Squibb BMY:US $ 5712M 33M
Celldex Therapeutics CLDX:US $ -16.57M 3.9M
Chemocentryx CCXI:US $ -20.8M 16.93M
CSL CSL:AU $ 1.19B 1.48B
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Flexion Therapeutics FLXN:US $ -23631000 7.27M
Genocea Biosciences GNCA:US $ -11.32M 2.86M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Glaxosmithkline GSK:US $ 3660M 1034M
Johnson & Johnson JNJ:US $ 8192M 2043M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Macrogenics MGNX:US $ -50191000 12.69M
Merck MRK:GR € 1551M 25M
Northwest Biotherapeutics NWBO:US -9954000 2.38M
Novartis NOVN:VX SF 4837M 65M
Novavax NVAX:US $ -302.88M 40.54M
Pfizer PFE:US $ 10235M 2245M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Veracyte VCYT:US $ -36.04M 41.77M
YTE INCY:US $ 262.16M 92.39M